Charles D. Goodwin's most recent trade in Apyx Medical Corp was a trade of 193,000 Stock Option (Option to Buy) done . Disclosure was reported to the exchange on May 15, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Apyx Medical Corp | Charles D. Goodwin | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2025 | 193,000 | 193,000 | - | - | Stock Option (Option to Buy) | |
| Apyx Medical Corp | Charles D. Goodwin | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 50,000 | 50,000 | - | - | Stock Option (Option to Buy) | |
| Apyx Medical Corp | Goodwin Charles D. | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jan 2024 | 243,000 | 0 | - | - | Stock Option (Option to Buy) | |
| Apyx Medical Corp | Charles D. Goodwin | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jan 2023 | 243,000 | 243,000 | - | - | Stock Option (Option to Buy) | |
| Apyx Medical Corp | Charles D. Goodwin | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 5.97 per share. | 29 Aug 2022 | 9,750 | 40,000 (0%) | 0% | 6.0 | 58,208 | Common Stock |
| Apyx Medical Corp | Charles D. Goodwin | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 5.93 per share. | 29 Aug 2022 | 2,000 | 30,250 (0%) | 0% | 5.9 | 11,860 | Common Stock |
| Apyx Medical Corp | Charles D. Goodwin | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2022 | 243,000 | 243,000 | - | - | Stock Option (Option to Buy) | |
| Apyx Medical Corp | Charles D. Goodwin | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2021 | 121,500 | 121,500 | - | - | Common Stock |